Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary Thromboembolism
NCT05512702
·
clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Embolism
Interventions
DRUG:
Tissue Plasminogen Activator, Alteplase
DRUG:
Low-molecular weight heparin
Sponsor
Ege University